← Evidence map

ArticleRevista clinica espanola2022

[Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic].

D Patoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

[Meta-analysis evaluating the risk of respiratory tract infections and acute respiratory distress syndrome with glucagon-like peptide-1 receptor agonists in cardiovascular outcome trials: Useful implications for the COVID-19 pandemic]. | OpenQuestion